Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine
The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully use...
Gespeichert in:
Veröffentlicht in: | American journal of epidemiology 2019-07, Vol.188 (7), p.1383-1388 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1388 |
---|---|
container_issue | 7 |
container_start_page | 1383 |
container_title | American journal of epidemiology |
container_volume | 188 |
creator | Yih, W Katherine Kulldorff, Martin Dashevsky, Inna Maro, Judith C |
description | The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully used to evaluate the safety of 2 vaccines for adolescents and young adults, but its suitability to study vaccines for older adults had not been established. The present study applied the method to assess the safety of live attenuated herpes zoster vaccination during 2011-2017 in US adults aged ≥60 years, using claims data from Truven Health MarketScan Research Databases. Counts of International Classification of Diseases diagnosis codes recorded in emergency department or hospital settings were scanned for any statistically unusual clustering within a hierarchical tree structure of diagnoses and within 42 days after vaccination. Among 1.24 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications . . ." on days 1-3, and nonspecific allergy on days 1-6. These results are consistent with local injection-site reactions and other known, generally mild, vaccine-associated adverse events and a favorable safety profile. This method might be useful for assessing the safety of other vaccines for older adults. |
doi_str_mv | 10.1093/aje/kwz104 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232130951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2429047036</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-a0e1e9e795c68710a4fca12021711212d57b99e0711e8e6bb865d87f16e6cf3a3</originalsourceid><addsrcrecordid>eNpdkU1LAzEQhoMoWj8u_gAJeBFhdSbZzW6OpfgFBQ-tHrwsaTqrW7ebmmSV-utdqXrwNAw878MwL2PHCBcIWl6aBV2-fnwipFtsgGmuEiUytc0GACASLZTYY_shLAAQdQa7bE8iKFGkMGDxIdTtM48vxCfUVMnItdG7pqE5n3qiZErLlfOm4RNrWj6JJtYh1pZHx4chUAibqKkorrmr-Lh-Jz6MkdrOxF5yS35FgT-5EMnzR2Nt3dIh26lME-joZx6wh-ur6eg2Gd_f3I2G48RKzGJigJA05TqzqsgRTFpZgwIE5ogCxTzLZ1oT9BsVpGazQmXzIq9QkbKVNPKAnW28K-_eOgqxXNbBUtOYllwXSiGkQAk6wx49_YcuXOfb_rpSpEJDmoNUPXW-oax3IXiqypWvl8avS4Tyu4uy76LcdNHDJz_Kbrak-R_6-3z5BS01hNM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2429047036</pqid></control><display><type>article</type><title>Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Yih, W Katherine ; Kulldorff, Martin ; Dashevsky, Inna ; Maro, Judith C</creator><creatorcontrib>Yih, W Katherine ; Kulldorff, Martin ; Dashevsky, Inna ; Maro, Judith C</creatorcontrib><description>The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully used to evaluate the safety of 2 vaccines for adolescents and young adults, but its suitability to study vaccines for older adults had not been established. The present study applied the method to assess the safety of live attenuated herpes zoster vaccination during 2011-2017 in US adults aged ≥60 years, using claims data from Truven Health MarketScan Research Databases. Counts of International Classification of Diseases diagnosis codes recorded in emergency department or hospital settings were scanned for any statistically unusual clustering within a hierarchical tree structure of diagnoses and within 42 days after vaccination. Among 1.24 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications . . ." on days 1-3, and nonspecific allergy on days 1-6. These results are consistent with local injection-site reactions and other known, generally mild, vaccine-associated adverse events and a favorable safety profile. This method might be useful for assessing the safety of other vaccines for older adults.</description><identifier>ISSN: 0002-9262</identifier><identifier>EISSN: 1476-6256</identifier><identifier>DOI: 10.1093/aje/kwz104</identifier><identifier>PMID: 31062840</identifier><language>eng</language><publisher>United States: Oxford Publishing Limited (England)</publisher><subject>Adolescents ; Adults ; Aged ; Allergies ; Cellulitis ; Clustering ; Complications ; Data Mining ; Drug-Related Side Effects and Adverse Reactions - epidemiology ; Emergency medical care ; Emergency medical services ; Female ; Herpes zoster ; Herpes Zoster - epidemiology ; Herpes Zoster - prevention & control ; Herpes Zoster Vaccine - adverse effects ; Humans ; Immunization ; Male ; Middle Aged ; Older people ; Patient Safety ; Research design ; Safety ; Structural hierarchy ; United States - epidemiology ; Vaccines ; Vaccines, Attenuated - adverse effects ; Young adults</subject><ispartof>American journal of epidemiology, 2019-07, Vol.188 (7), p.1383-1388</ispartof><rights>The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-a0e1e9e795c68710a4fca12021711212d57b99e0711e8e6bb865d87f16e6cf3a3</citedby><cites>FETCH-LOGICAL-c315t-a0e1e9e795c68710a4fca12021711212d57b99e0711e8e6bb865d87f16e6cf3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31062840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yih, W Katherine</creatorcontrib><creatorcontrib>Kulldorff, Martin</creatorcontrib><creatorcontrib>Dashevsky, Inna</creatorcontrib><creatorcontrib>Maro, Judith C</creatorcontrib><title>Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine</title><title>American journal of epidemiology</title><addtitle>Am J Epidemiol</addtitle><description>The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully used to evaluate the safety of 2 vaccines for adolescents and young adults, but its suitability to study vaccines for older adults had not been established. The present study applied the method to assess the safety of live attenuated herpes zoster vaccination during 2011-2017 in US adults aged ≥60 years, using claims data from Truven Health MarketScan Research Databases. Counts of International Classification of Diseases diagnosis codes recorded in emergency department or hospital settings were scanned for any statistically unusual clustering within a hierarchical tree structure of diagnoses and within 42 days after vaccination. Among 1.24 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications . . ." on days 1-3, and nonspecific allergy on days 1-6. These results are consistent with local injection-site reactions and other known, generally mild, vaccine-associated adverse events and a favorable safety profile. This method might be useful for assessing the safety of other vaccines for older adults.</description><subject>Adolescents</subject><subject>Adults</subject><subject>Aged</subject><subject>Allergies</subject><subject>Cellulitis</subject><subject>Clustering</subject><subject>Complications</subject><subject>Data Mining</subject><subject>Drug-Related Side Effects and Adverse Reactions - epidemiology</subject><subject>Emergency medical care</subject><subject>Emergency medical services</subject><subject>Female</subject><subject>Herpes zoster</subject><subject>Herpes Zoster - epidemiology</subject><subject>Herpes Zoster - prevention & control</subject><subject>Herpes Zoster Vaccine - adverse effects</subject><subject>Humans</subject><subject>Immunization</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Older people</subject><subject>Patient Safety</subject><subject>Research design</subject><subject>Safety</subject><subject>Structural hierarchy</subject><subject>United States - epidemiology</subject><subject>Vaccines</subject><subject>Vaccines, Attenuated - adverse effects</subject><subject>Young adults</subject><issn>0002-9262</issn><issn>1476-6256</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1LAzEQhoMoWj8u_gAJeBFhdSbZzW6OpfgFBQ-tHrwsaTqrW7ebmmSV-utdqXrwNAw878MwL2PHCBcIWl6aBV2-fnwipFtsgGmuEiUytc0GACASLZTYY_shLAAQdQa7bE8iKFGkMGDxIdTtM48vxCfUVMnItdG7pqE5n3qiZErLlfOm4RNrWj6JJtYh1pZHx4chUAibqKkorrmr-Lh-Jz6MkdrOxF5yS35FgT-5EMnzR2Nt3dIh26lME-joZx6wh-ur6eg2Gd_f3I2G48RKzGJigJA05TqzqsgRTFpZgwIE5ogCxTzLZ1oT9BsVpGazQmXzIq9QkbKVNPKAnW28K-_eOgqxXNbBUtOYllwXSiGkQAk6wx49_YcuXOfb_rpSpEJDmoNUPXW-oax3IXiqypWvl8avS4Tyu4uy76LcdNHDJz_Kbrak-R_6-3z5BS01hNM</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Yih, W Katherine</creator><creator>Kulldorff, Martin</creator><creator>Dashevsky, Inna</creator><creator>Maro, Judith C</creator><general>Oxford Publishing Limited (England)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20190701</creationdate><title>Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine</title><author>Yih, W Katherine ; Kulldorff, Martin ; Dashevsky, Inna ; Maro, Judith C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-a0e1e9e795c68710a4fca12021711212d57b99e0711e8e6bb865d87f16e6cf3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescents</topic><topic>Adults</topic><topic>Aged</topic><topic>Allergies</topic><topic>Cellulitis</topic><topic>Clustering</topic><topic>Complications</topic><topic>Data Mining</topic><topic>Drug-Related Side Effects and Adverse Reactions - epidemiology</topic><topic>Emergency medical care</topic><topic>Emergency medical services</topic><topic>Female</topic><topic>Herpes zoster</topic><topic>Herpes Zoster - epidemiology</topic><topic>Herpes Zoster - prevention & control</topic><topic>Herpes Zoster Vaccine - adverse effects</topic><topic>Humans</topic><topic>Immunization</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Older people</topic><topic>Patient Safety</topic><topic>Research design</topic><topic>Safety</topic><topic>Structural hierarchy</topic><topic>United States - epidemiology</topic><topic>Vaccines</topic><topic>Vaccines, Attenuated - adverse effects</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yih, W Katherine</creatorcontrib><creatorcontrib>Kulldorff, Martin</creatorcontrib><creatorcontrib>Dashevsky, Inna</creatorcontrib><creatorcontrib>Maro, Judith C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yih, W Katherine</au><au>Kulldorff, Martin</au><au>Dashevsky, Inna</au><au>Maro, Judith C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine</atitle><jtitle>American journal of epidemiology</jtitle><addtitle>Am J Epidemiol</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>188</volume><issue>7</issue><spage>1383</spage><epage>1388</epage><pages>1383-1388</pages><issn>0002-9262</issn><eissn>1476-6256</eissn><abstract>The self-controlled tree-temporal scan statistic allows detection of potential vaccine- or drug-associated adverse events without prespecifying the specific events or postexposure risk intervals of concern. It thus opens a promising new avenue for safety studies. The method has been successfully used to evaluate the safety of 2 vaccines for adolescents and young adults, but its suitability to study vaccines for older adults had not been established. The present study applied the method to assess the safety of live attenuated herpes zoster vaccination during 2011-2017 in US adults aged ≥60 years, using claims data from Truven Health MarketScan Research Databases. Counts of International Classification of Diseases diagnosis codes recorded in emergency department or hospital settings were scanned for any statistically unusual clustering within a hierarchical tree structure of diagnoses and within 42 days after vaccination. Among 1.24 million vaccinations, 4 clusters were found: cellulitis on days 1-3, nonspecific erythematous condition on days 2-4, "other complications . . ." on days 1-3, and nonspecific allergy on days 1-6. These results are consistent with local injection-site reactions and other known, generally mild, vaccine-associated adverse events and a favorable safety profile. This method might be useful for assessing the safety of other vaccines for older adults.</abstract><cop>United States</cop><pub>Oxford Publishing Limited (England)</pub><pmid>31062840</pmid><doi>10.1093/aje/kwz104</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9262 |
ispartof | American journal of epidemiology, 2019-07, Vol.188 (7), p.1383-1388 |
issn | 0002-9262 1476-6256 |
language | eng |
recordid | cdi_proquest_miscellaneous_2232130951 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adolescents Adults Aged Allergies Cellulitis Clustering Complications Data Mining Drug-Related Side Effects and Adverse Reactions - epidemiology Emergency medical care Emergency medical services Female Herpes zoster Herpes Zoster - epidemiology Herpes Zoster - prevention & control Herpes Zoster Vaccine - adverse effects Humans Immunization Male Middle Aged Older people Patient Safety Research design Safety Structural hierarchy United States - epidemiology Vaccines Vaccines, Attenuated - adverse effects Young adults |
title | Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20the%20Self-Controlled%20Tree-Temporal%20Scan%20Statistic%20to%20Assess%20the%20Safety%20of%20Live%20Attenuated%20Herpes%20Zoster%20Vaccine&rft.jtitle=American%20journal%20of%20epidemiology&rft.au=Yih,%20W%20Katherine&rft.date=2019-07-01&rft.volume=188&rft.issue=7&rft.spage=1383&rft.epage=1388&rft.pages=1383-1388&rft.issn=0002-9262&rft.eissn=1476-6256&rft_id=info:doi/10.1093/aje/kwz104&rft_dat=%3Cproquest_cross%3E2429047036%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2429047036&rft_id=info:pmid/31062840&rfr_iscdi=true |